Testing a blood-building medication to improve survival after severe trauma

This trial is testing whether epoetin alfa, a medication that helps build red blood cells, can improve survival and reduce disability in people who are critically ill after a traumatic injury. The study will compare patients who receive this medication to those who receive a placebo (a dummy injection) to see if the treatment makes a real difference in outcomes at six months after injury.

Despite the best available care, many trauma patients die or face long-term disability after their injuries. This medication has shown promise in animal studies for protecting vital organs like the brain, heart, and kidneys, and for reducing harmful inflammation—so researchers want to test whether it can actually help trauma patients survive and recover better.